(Q46907771)

26 December 2017

title

A randomized trial comparing losartan with amlodipine as initial therapy for hypertension in the early post-transplant period (English)

1 reference

26 December 2017

1 reference

Richard N Formica

1

1 reference

26 December 2017

Amy L Friedman

2

1 reference

26 December 2017

Marc I Lorber

3

1 reference

26 December 2017

J Douglas Smith

4

1 reference

26 December 2017

Tom Eisen

5

1 reference

26 December 2017

Margaret J Bia

6

1 reference

26 December 2017

language of work or name

English

0 references

publication date

23 January 2006

1 reference

26 December 2017

Nephrology Dialysis Transplantation

published in

1 reference

26 December 2017

volume

21

1 reference

26 December 2017

issue

5

1 reference

26 December 2017

page(s)

1389-1394

1 reference

26 December 2017

A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension

cites work

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFK058

Blockade of the renin-angiotensin system: better late than never

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFK058

Blockade of the renin-angiotensin system increases graft survival in patients with chronic allograft nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFK058

Angiotensin converting enzyme inhibition in chronic allograft nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFK058

Angiotensin II type 1 (AT1) receptor antagonists in the treatment of hypertension after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFK058

Angiotensin-II receptor antagonist losartan reduces microalbuminuria in hypertensive renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFK058

Effect of angiotensin II receptor blocker on plasma levels of TGF-beta 1 and interstitial fibrosis in hypertensive kidney transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFK058

Sustained improvement of renal graft function for two years in hypertensive renal transplant recipients treated with nifedipine as compared to lisinopril

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFK058

Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers used for the treatment of hypertension appear to be safe in the early posttransplant period

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFK058

Angiotensin II induces apoptosis in renal proximal tubular cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFK058

Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFK058

Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFK058

Renoprotective benefits of RAS inhibition: from ACEI to angiotensin II antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFK058

Effects of losartan or enalapril on hemoglobin, circulating erythropoietin, and insulin-like growth factor-1 in patients with and without posttransplant erythrocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFK058

21 January 2018

Identifiers

DOI

10.1093/NDT/GFK058

1 reference

26 December 2017

1 reference

26 December 2017